1-3 of 3
Shannon Winski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical characterization of a novel, wild-type-sparing, JAK2 V617F mutant-selective inhibitor

Free
Mark Chicarelli, Michelle Crow, Kim Alley, Tanna Bettendorf, Abiezer Blandon, Alexandra Born, Richard Brizendine, Paul Carlson, Payal Chatterjee, Brad Fell, John Fischer, Jennifer Fulton, Anna Guarnieri, Ravi Jalluri, Amber Johnson, Keith Koch, Vijay Kumar, Cori Malinky, Matt McDonald, Colin Mchugh, Maralee McVean, Brad Newhouse, Scott Niman, Rob Rieger, John Robinson, Mareli Rodriguez, Leah Salituro, Patrick Salvo, Francis Sullivan, John Trujillo, Brooklynn Venteicher, Logan Vine, Shannon Winski, Hannan Work, Yeyun Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 3752.
https://doi.org/10.1182/blood-2025-3752
Published: 2025
Journal Articles

Relationship between KIT inhibition by bezuclastinib and effects on disease burden in mouse models of systemic mastocytosis

Free
Michelle Crow, Karyn Bouhana, Eric Brown, LouAnn Cable, Rachael Easton, Anna Guarnieri, Keith Koch, John Robinson, Francis Sullivan, Shannon Winski
Journal: Blood
Blood (2025) 146 (Supplement 1): 5531.
https://doi.org/10.1182/blood-2025-5531
Published: 2025
Journal Articles

Preclinical Data with KIT D816V Inhibitor Bezuclastinib (CGT9486) Demonstrates High Selectivity and Minimal Brain Penetrance

Free
Anna Guarnieri, Mark Chicarelli, Louann Cable, Karyn Bouhana, Francis Sullivan, Howard Ball, Jessica Sachs, Shannon Winski, John Robinson
Journal: Blood
Blood (2021) 138 (Supplement 1): 4595.
https://doi.org/10.1182/blood-2021-152770
Published: 2021